Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
4.500
+0.590 (15.09%)
At close: Feb 27, 2026, 4:00 PM EST
4.470
-0.030 (-0.67%)
After-hours: Feb 27, 2026, 7:13 PM EST
Intelligent Bio Solutions Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2017 |
| Operating Revenue | 3.58 | 3.05 | 3.11 | 1.26 | - | - | Upgrade
|
| Other Revenue | - | - | - | - | - | 1.98 | Upgrade
|
| Revenue | 3.58 | 3.05 | 3.11 | 1.26 | - | 1.98 | Upgrade
|
| Revenue Growth (YoY) | 18.14% | -1.90% | 147.58% | - | - | 949.30% | Upgrade
|
| Cost of Revenue | 1.93 | 1.81 | 1.69 | 0.93 | - | - | Upgrade
|
| Gross Profit | 1.65 | 1.25 | 1.43 | 0.33 | - | 1.98 | Upgrade
|
| Selling, General & Admin | 10.12 | 8.88 | 9.26 | 8.03 | 4.92 | 3.36 | Upgrade
|
| Research & Development | 1.95 | 2.4 | 1.67 | 0.51 | 3.85 | 3.84 | Upgrade
|
| Other Operating Expenses | -0.82 | -0.82 | -0.42 | -0.74 | -0.44 | - | Upgrade
|
| Operating Expenses | 12.44 | 11.67 | 11.71 | 8.76 | 8.34 | 7.19 | Upgrade
|
| Operating Income | -10.78 | -10.42 | -10.28 | -8.44 | -8.34 | -5.21 | Upgrade
|
| Interest Expense | -0.09 | -0.06 | -0.17 | -0.22 | -0.01 | -1.09 | Upgrade
|
| Interest & Investment Income | 0.04 | 0.1 | 0.08 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -0.14 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0.01 | -0 | -0.27 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 0.18 | 2.15 | - | -0.36 | Upgrade
|
| EBT Excluding Unusual Items | -10.83 | -10.38 | -10.19 | -6.51 | -8.33 | -7.06 | Upgrade
|
| Impairment of Goodwill | - | - | - | -4.16 | - | - | Upgrade
|
| Asset Writedown | -0.51 | -0.22 | - | - | - | - | Upgrade
|
| Pretax Income | -11.33 | -10.6 | -10.19 | -10.66 | -8.33 | -7.06 | Upgrade
|
| Earnings From Continuing Operations | -11.33 | -10.6 | -10.19 | -10.66 | -8.33 | -7.06 | Upgrade
|
| Minority Interest in Earnings | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | Upgrade
|
| Net Income | -11.29 | -10.57 | -10.16 | -10.63 | -8.31 | -7.04 | Upgrade
|
| Net Income to Common | -11.29 | -10.57 | -10.16 | -10.63 | -8.31 | -7.04 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 0 | - | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 0 | - | - | - | Upgrade
|
| Shares Change (YoY) | 126.92% | 231.10% | - | - | - | - | Upgrade
|
| EPS (Basic) | -14.67 | -20.04 | -63.77 | - | - | - | Upgrade
|
| EPS (Diluted) | -14.67 | -20.04 | -63.80 | - | - | - | Upgrade
|
| Free Cash Flow | -9.74 | -9.91 | -9.79 | -7.88 | -3.74 | -11.3 | Upgrade
|
| Free Cash Flow Per Share | -12.65 | -18.79 | -61.48 | - | - | - | Upgrade
|
| Gross Margin | 46.21% | 40.85% | 45.81% | 25.99% | - | 100.00% | Upgrade
|
| Operating Margin | -301.04% | -341.50% | -330.46% | -671.24% | - | -263.28% | Upgrade
|
| Profit Margin | -315.37% | -346.23% | -326.40% | -845.89% | - | -355.33% | Upgrade
|
| Free Cash Flow Margin | -272.00% | -324.62% | -314.71% | -627.15% | - | -570.39% | Upgrade
|
| EBITDA | -9.84 | -9.45 | -9.31 | -7.62 | - | - | Upgrade
|
| EBITDA Margin | -274.66% | - | -299.15% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.94 | 0.97 | 0.97 | 0.81 | - | - | Upgrade
|
| EBIT | -10.78 | -10.42 | -10.28 | -8.44 | -8.34 | -5.21 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -263.28% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 1.98 | Upgrade
|
| Advertising Expenses | - | 1.55 | 0.73 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.